Just Under 2 Weeks Until SMi’s 2nd Annual AI in Drug Delivery 2021, Sponsored by CAS, Dassault Systèmes and Gero
Summary
London, United Kingdom, March 06, 2021 --( It is crucial for scientific researchers to stay on top of the latest advancements, technologies and processes related to artificial intelligence in drug discovery. SMi Group is delighted to be working with a number of industry experts from within the field of AI in drug discovery and are proud to welcome the sponsors of the conference, CAS, Dassault Systèmes & Gero. Presented by Peter Fedichev, CEO and Founder at Gero.ai Gero is the next-gen AI drug discovery company utilizing real-world big clinical, genetic (WES), and molecular data from vast human cohorts instead of animal models to help their partners create revolutionary medicines against complex diseases. Covering hot topics like machine learning techniques for improving early drug discovery, effective prediction of ADMET properties, data quality, and innovative applications of AI for undruggable targets, this conference has gathered experts representing top organisations to share their key insights at the virtual conference.With less than 2 weeks to go and registration closes next week, interested parties can register at £999 for vendors and commercial firms and £499 for pharmaceutical and biotechnology companies on http://www.ai-indrugdiscovery.com/pr5.SMi Group is delighted to be working with a number of industry experts from within the field of AI in drug discovery and are proud to welcome the sponsors of the conference, CAS, Dassault Systèmes & Gero. With more than 110 years experience, CAS are leaders of the industry.Day Two - How does AI help to utilize Genetic, Transcriptomic And Clinical Data for Target Identification in Complex Diseases?Presented by Peter Fedichev, CEO and Founder at Gero.aiGero is the next-gen AI drug discovery company utilizing real-world big clinical, genetic (WES), and molecular data from vast human cohorts instead of animal models to help their partners create revolutionary medicines against complex diseases.The full speaker line up, brochure and agenda is available at http://www.ai-indrugdiscovery.com/pr5Sponsored by: CAS, Dassault Systems and GeroParties interested in sponsoring, exhibiting or speaking at this event can contact Alia Malick, Director, on +44 (0) 20 827 6168 or email amalick@smi-online.co.ukFor media enquiries, contact Simi Sapal on +44 (0) 20 7827 6162 or ssapal@smi-online.co.ukSMi’s 2nd Annual AI in Drug Discovery ConferenceConference: 15 – 16 March 2021Virtual Conference: Online Access Onlyhttp://www.ai-indrugdiscovery.com/pr5#SMiAIinDrugDisAbout SMi Group:Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities.
Classifications
AskAI Classifications
LabelsLinked Companies
